SciELO - Scientific Electronic Library Online

 
vol.22 número2Argón plasma versus formol al 4% en el manejo endoscópico de la proctitis actínica sangrante índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista colombiana de Gastroenterología

versión impresa ISSN 0120-9957versión On-line ISSN 2500-7440

Resumen

GAGGERO, Patricia; OLANO GOSSWEILER, Carolina; TOLVE TILBE, Julio  y  ZEBALLOS ZAS, Elbio Juan. Anticardiolipin antibodies and lupus anticoagulation inhibitor in adult celiac patients. Rev Col Gastroenterol [online]. 2007, vol.22, n.2, pp.83-86. ISSN 0120-9957.

Celiac disease (CD) is an autoimmune enteropathy affecting the small intestine in genetically predisposed children and adults, triggered by the ingestion of gluten-containing foods. It is usually associated to other immunological diseases. Due to the relation between anticardiolipin antibodies and lupus anticoagulation inhibitor with immunological diseases, a study was performed to determinate the prevalence of these antibodies, comparing their prevalence in the general population. It was taken into account the existence of venous or arterial thrombosis and repetitive miscarriage. 30 celiac patients were evaluated, 25 women and 5 men. Only one had the anticardiolipin antibody positive. None of them had thrombotic or miscarriage background. It was concluded that the prevalence of ACA and AL in celiac patients is not higher than in the general population, and it was not even possible to demonstrate an association with an antiphospholipid syndrome.

Palabras clave : Celiac disease; anticardiolipin antibodies; lupus anticoagulation inhibitor; antiphospholipid antibodies.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons